Cargando…
Implementing the 4R and 9H regimens for TB preventive treatment in Indonesia
BACK GROUND: The implementation of tuberculosis preventive treatment (TPT) is challenging especially in resource-limited settings. As part of a Phase 3 trial on TPT, we described our experience with the use of rifampicin for 4 months (4R) and isoniazid for 9 months (9H) in Indonesia. METHODS: In 201...
Autores principales: | Apriani, L., Koesoemadinata, R. C., Bastos, M. L., Wulandari, D. A., Santoso, P., Alisjahbana, B., Rutherford, M. E., Hill, P. C., Benedetti, A., Menzies, D., Ruslami, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Union
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802562/ https://www.ncbi.nlm.nih.gov/pubmed/35086621 http://dx.doi.org/10.5588/ijtld.21.0318 |
Ejemplares similares
-
Mycobacterium tuberculosis infection and disease in healthcare workers in a tertiary referral hospital in Bandung, Indonesia
por: Apriani, Lika, et al.
Publicado: (2022) -
Sensitivity of the Quantiferon-Gold In-Tube Assay in Sputum Smear Positive TB Cases in Indonesia
por: Rutherford, Merrin, et al.
Publicado: (2010) -
High dose rifampin for 2 months vs standard dose rifampin for 4 months, to treat TB infection: Protocol of a 3-arm randomized trial (2R(2))
por: Fregonese, Federica, et al.
Publicado: (2023) -
Factors associated with treatment outcome of MDR/RR-TB patients treated with shorter injectable based regimen in West Java Indonesia
por: Soeroto, Arto Yuwono, et al.
Publicado: (2022) -
COVID-19 impact on health service- and TB-related practices among private providers in Indonesia
por: Lestari, B. W., et al.
Publicado: (2023)